Q: Please describe this drug.
 The Compound has the SMILES CCOC(=O)c1ncn2c1CN(C)C(=O)c1c(I)cccc1-2.
Answer: Iomazenil is under investigation in clinical trial NCT01590277 (Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans).
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CCOC(=O)c1ncn2c1CN(C)C(=O)c1c(I)cccc1-2
CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC=C3I)C
ethyl 7-iodo-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
Please describe this drug.
Iomazenil is under investigation in clinical trial NCT01590277 (Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans).